Risk of lymphoma in patients with RA treated with anti-TNFalpha agents (Q35555473)

8 August 2017

1 reference

title

Risk of lymphoma in patients with RA treated with anti-TNFalpha agents (English)

1 reference

8 August 2017

2

D P M Symmons

1 reference

8 August 2017

J P Franklin

1

1 reference

PubMed ID

15834052

8 August 2017

A J Silman

series ordinal

3

1 reference

PubMed ID

15834052

8 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

Annals of the Rheumatic Diseases

8 August 2017

1 reference

8 August 2017

64

1 reference

8 August 2017

5

1 reference

8 August 2017

657-658

1 reference

Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755469

The use of TNF-alpha blocking agents in rheumatoid arthritis: an overview

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755469

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755469

Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755469

A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755469

Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755469

The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755469

Cancer morbidity in rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755469

Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755469

Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755469

Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755469

Intravascular lymphoma presenting as symmetric polyarthritis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755469

Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis

26 September 2018

1 reference

12 December 2020

Lack of certainty on the diagnosis of acute intermittent porphyria: comment on the concise communication by Cohen et al

1 reference

12 December 2020

Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases

1 reference

12 December 2020

Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.2005.035311

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

PubMed ID

15834052